Report
Pharmaceuticals | Our key take-aways from ESMO 2019
SECTOR | Pharmaceuticals | Our key take-aways from ESMO 2019A few years ago, we were predicting that IO would occupy the lion’s share of future ESMO sessions but actually this has not been the case and targeted therapies (many of which are small molecules) are still playing a key role.
Provider
Bryan Garnier
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Eric Le Berrigaud
Other Reports from Bryan Garnier
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.